Postictal affective episodes

被引:36
作者
Kanner, Andres M. [1 ,2 ]
Trimble, Michael [3 ]
Schmitz, Bettina [4 ]
机构
[1] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA
[2] Rush Med Coll, Dept Neurol Sci, Chicago, IL 60612 USA
[3] Natl Hosp, Inst Neurol, London WC1N 3BG, England
[4] Humboldt Univ, Charite Virchow Klinikum, Neurol Klin, Berlin, Germany
关键词
Postictal depression; Postictal anxiety; Postictal suicidality; Pharmacoresistant epilepsy; TEMPORAL-LOBE EPILEPSY; PSYCHOSES; EVENTS;
D O I
10.1016/j.yebeh.2010.06.024
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Despite their recognition two centuries ago, postictal depression symptoms (PDSs) and episodes (PDEs) continue to be ignored by most clinicians in their evaluation of patients with epilepsy. And yet, PDSs are relatively frequent in patients with pharmacoresistant epilepsy, having been identified in almost 50% of patients with a median duration of 24 hours. PDSs may be the expression of symptoms restricted to the postictal period (defined as the first 5 days following a seizure) and/or may be the expression of postictal exacerbation in severity of interictal symptoms of depression. In fact, a past history of depressive and anxiety disorders has been associated with the occurrence of PDSs and PSEs. PDSs and PSEs often occur together with postictal symptoms of anxiety, and the occurrence of PDSs has been associated with more severe postictal cognitive deficits. The occurrence of PDSs and PDEs has not been associated with any epilepsy-related variable (location of seizure focus, MRI findings, type of antiepileptic drug). Prevention of PDSs and PDEs can be achieved only with seizure freedom, and preliminary uncontrolled data suggest that being on antidepressant medication does not protect patients from experiencing these types of symptoms. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:156 / 158
页数:3
相关论文
共 19 条
[1]  
[Anonymous], 1903, Psychiatrie
[2]   LIMBIC POSTICTAL EVENTS - ANATOMICAL SUBSTRATES AND OPIOID RECEPTOR INVOLVEMENT [J].
CALDECOTTHAZARD, S ;
ENGEL, J .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1987, 11 (04) :389-418
[3]  
CALDECOTTHAZARD S, 1984, NEUROTRANSMITTERS SE, P305
[4]  
CARROLL MN, 1960, ARCH INT PHARMACOD T, V125, P383
[5]   POSTICTAL PSYCHOSIS - A CASE-CONTROL SERIES OF 20 PATIENTS AND 150 CONTROLS [J].
DEVINSKY, O ;
ABRAMSON, H ;
ALPER, K ;
FITZGERALD, LS ;
PERRINE, K ;
CALDERON, J ;
LUCIANO, D .
EPILEPSY RESEARCH, 1995, 20 (03) :247-253
[6]  
Engel J Jr, 1991, Adv Neurol, V55, P97
[7]   MU-OPIATE RECEPTORS MEASURED BY POSITRON EMISSION TOMOGRAPHY ARE INCREASED IN TEMPORAL-LOBE EPILEPSY [J].
FROST, JJ ;
MAYBERG, HS ;
FISHER, RS ;
DOUGLASS, KH ;
DANNALS, RF ;
LINKS, JM ;
WILSON, AA ;
RAVERT, HT ;
ROSENBAUM, AE ;
SNYDER, SH ;
WAGNER, HN .
ANNALS OF NEUROLOGY, 1988, 23 (03) :231-237
[8]  
Gowers WR., 1881, Epilepsy and other chronic convulsive diseases
[9]  
their causes, symptoms and treatment
[10]  
HITZEMANN RJ, 1987, MOL PHARMACOL, V31, P562